Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Does the Forecast Indicate for the Mutation Detection Kits In Genome Editing Market From 2025 to 2029?
In recent times, the market size of mutation detection kits in the genome editing sector has witnessed prompt escalation. By 2024, it is projected to be valued at $1.01 billion before leaping to $1.14 billion in 2025, denoting an impressive compound annual growth rate (CAGR) of 13.4%. This significant surge during the historic period can be connected to the intensification in research pertaining to genetic ailments, amplified government backing for genomics, escalating collaborations in academic and clinical research, the increased accessibility of sophisticated molecular biology tools, and the upswing in investments from biotech corporations.
In the genome editing market, the mutation detection kits are anticipated to grow significantly in the next few years. This market is projected to reach $1.86 billion in 2029, increasing at a compound annual growth rate (CAGR) of 13.1%. A surge in the adoption of autonomous mobile robots (AMRs), increased emphasis on supply chain visibility, significant investments in digital twin technologies, an increased need for real-time asset tracking, and a rising adoption of industrial automation can all contribute to this growth during the forecast period. The forecast period is also likely to see key trends including advancements in real-time location systems (RTLS), breakthroughs in AI-powered asset tracking, the merging of RFID with IoT platforms, advancements in ultra-wideband (UWB) technology, and the incorporation of digital twin solutions in industrial automation.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27356&type=smp
What Elements Are Contributing To Growth In The Mutation Detection Kits In Genome Editing Market?
The increasing occurrence of genetic disorders is anticipated to drive the expansion of the mutation detection kits in the genome editing market. Genetic disorders, diseases or conditions caused by DNA abnormalities that can be inherited or result from new genetic mutations, are on the rise due to more awareness and advanced diagnostic technologies. These advancements enable faster and more precise condition identification, leading to increased reported prevalence rates. Through the accurate identification of mutations causing diseases, genome editing mutation detection kits aid in addressing genetic disorders. They facilitate targeted research and the creation of exact therapeutic interventions. For example, the National Health Service, a government department based in the UK, reported in May 2024 that approximately 17,000 people in England live with sickle cell disease, an inherited blood disorder, with about 250 new diagnoses each year. Consequently, the escalating prevalence of genetic disorders is fuelling the growth of the mutation detection kits in the genome editing market.
Which Segments Are Detailed In The Global Mutation Detection Kits In Genome Editing Market Report?
The mutation detection kits in genome editing market covered in this report is segmented
1) By Product Type: Reagents, Kits, Software Solutions
2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nucleases Or Meganuclease-TAL Effector Nucleases (TALENs/MegaTALs), Zinc Finger Nucleases (ZFN), Other Technologies
3) By Application: Research, Clinical Diagnostics, Drug Development, Other Applications
4) By End Use: Academic Institutions, Hospitals And Diagnostic Centers, Biotechnology Companies
Subsegments:
1) By Reagents: Deoxyribonucleic Acid Polymerases (DNA) Polymerases, Nucleases, Buffers And Enzymes, Fluorescent Dyes And Probes, Primers And Oligonucleotides
2) By Kits: Polymerase Chain Reaction (PCR)-Based Mutation Detection Kits, Next-Generation Sequencing-Based Mutation Analysis Kits, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Mutation Validation Kits, Gel Electrophoresis-Based Detection Kits
3) By Software Solutions: Mutation Analysis And Visualization Tools, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Off-Target Prediction Software, Genomic Alignment and Annotation Software, Data Interpretation Platforms For Next-Generation Sequencing, Cloud-Based Bioinformatics Platforms
Which Emerging Trends And Strategic Shifts Are Shaping The Mutation Detection Kits In Genome Editing Market?
Leading firms in the genome editing market, particularly in mutation detection kits, are prioritizing the creation of cutting-edge products like ultrasensitive multiplexed assays, geared at boosting accuracy, pace, and sensitivity in identifying genetic mutations. These advanced diagnostic tests have the ability to concurrently detect and quantify multiple genetic mutations at extremely low levels, thus providing quicker, more accurate, and in-depth mutation analysis that can enhance disease diagnosis and treatment tracking. For example, the ddPLEX ESR1 Mutation Detection Kit, an ultrasensitive multiplexed digital PCR assay created for breast cancer mutation detection, was unveiled by Bio-Rad Laboratories Inc., a research company based in the US in April 2024. This kit gives a simultaneous identification and precise quantification of seven ESR1 mutations with an analytical sensitivity as low as 0.01% variant allele fraction, and it is compatible with both plasma and tissue sample analysis. These advances reflect the industry’s dedication to enhancing diagnostic precision and the development of more effective disease monitoring and personalized treatment strategies.
Who Are The Key Contributors To Growth In The Mutation Detection Kits In Genome Editing Market?
Major companies operating in the mutation detection kits in genome editing market are F. Hoffmann-La Roche Ltd, Merck KGaA, Thermo Fisher Scientific Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena AG, Twist Bioscience Corporation, New England Biolabs Inc., Applied Biological Materials Inc., Synthego Corporation, Cell Signaling Technology Inc., BioVision Inc., Creative Biogene Corporation.
Get The Full Report Here:
Which Region Is Projected To Lead The Mutation Detection Kits In Genome Editing Market By 2025?
North America was the largest region in the mutation detection kits in genome editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mutation detection kits in genome editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27356&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model